MENU

SAGE Sage Therapeutics Forecast, Technical & Fundamental Analysis

a developer of therapeutics and medicines for central nervous system disorders

Industry Biotechnology
SAGE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
SAGE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SAGE is expected to report earnings to fall 8.82% to -154 cents per share on October 29

Sage Therapeutics SAGE Stock Earnings Reports
Q3'24
Est.
$-1.55
Q2'24
Missed
by $0.06
Q1'24
Missed
by $0.15
Q4'23
Beat
by $0.73
Q3'23
Missed
by $0.69
The last earnings report on July 31 showed earnings per share of -170 cents, missing the estimate of -163 cents. With 659.99K shares outstanding, the current market capitalization sits at 445.06M.
A.I. Advisor
published General Information

General Information

a developer of therapeutics and medicines for central nervous system disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
215 First Street
Phone
+1 617 299-8380
Employees
487
Web
https://www.sagerx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY577.99-5.33
-0.91%
SPDR® S&P 500® ETF Trust
BTC.X66432.195000-929.210940
-1.38%
Bitcoin cryptocurrency
GME20.54-0.39
-1.86%
GameStop Corp
TSLA213.65-4.32
-1.98%
Tesla
AAPL230.76-5.10
-2.16%
Apple

SAGE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SAGE has been loosely correlated with NTLA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SAGE jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAGE
1D Price
Change %
SAGE100%
N/A
NTLA - SAGE
46%
Loosely correlated
-5.41%
BEAM - SAGE
46%
Loosely correlated
-4.05%
CRSP - SAGE
46%
Loosely correlated
-4.25%
VIR - SAGE
43%
Loosely correlated
-1.18%
ALLO - SAGE
42%
Loosely correlated
-1.07%
More